Politecnico di Torino - Corso Duca degli Abruzzi, 24 - 10129 Torino, ITALY

+39 011 090 6100 info@tech-share.it

Solution for the treatment of skin diseases

cytocidal effectinfection preventionpre-treated gauzeskin lesions


The invention consists of a pre-medicated solid hydrogel gauze designed to treat wounds and skin burns, able to prevent the development of microbial infections, thanks to its cytocidal capacity against a wide spectrum of bacterial species generally involved in human skin infections.

Garza pre-medicata

Technical features

The innovative pre-medicated gauze contains some active ingredients of natural origin, obtained as by-products of the essential oils production. Thanks to the proposed formula, the solution has antimicrobial properties necessary for antipathogenic activity against different cutaneous bacterial pathogens (eg.Staphylococcus spp, Streptococcus spp, Enterococcus spp, Pseudomonas spp) and fungal ones (eg.Candida spp), which are sensitive or resistant to antimicrobials. The patented solution allows the timed release of the active ingredients contained in the gel. Thus, it enables a continuous and gradual treatment of the damaged skin area, while stimulating a local immune response. Laboratory tests proved its cytocidal properties, investigating on the basic gauze prototype’s performance in vitro.

Possible Applications

In hospitals and at home, for the treatment of:

  • Bedsores;
  • Postoperative wounds;
  • Burns.


  • Easy application and removal from the lesion, for a better wound treatment;
  • Reduction of healthcare costs related to development of wound infections;
  • Prevention of infections caused  by bacteria or fungi;